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Ophthalmic mycoses caused by infectious fungi are being recognized as a serious concern since they lead to total blindness.
Cephalosporium is one amongst several opportunistic fungal species implicated in ophthalmic infections leading to mycotic
keratitis. A mitogenic lectin has been puriﬁed from the mycelia of fungus Cephalosporium, isolated from the corneal smears of
a keratitis patient. Cephalosporium lectin (CSL) is a tetramer with subunit mass of 14kDa, agglutinates human A, B, and O
erythrocytes,andexhibitshighaﬃnityformucincomparedtofetuinandasialofetuinbutdoesnotbindtosimplesugarsindicating
its complex sugar speciﬁcity. CSL showed strong binding to normal human peripheral blood mononuclear cells (PBMCs) to elicit
mitogenicactivity.ThesugarspeciﬁcityofthelectinanditsinteractionwithPBMCstoexhibitmitogeniceﬀectindicateitspossible
role in adhesion and infection process of Cephalosporium.
1.Introduction
Ophthalmic infections caused by fungi rather than bacteria
are of serious concern in many developing countries as they
lead to blindness. Ocular fungal infections referred to as
ophthalmic mycoses are leading to keratitis of the cornea [1].
Several fungal species responsible for mycotic keratitis and
other forms of eye infections have been reviewed recently
[2,3].FusariumandCephalosporium(Acremonium)ar ewid e
spread fungal species that belong to hyaline ﬁlamentous
group which are implicated for ophthalmic mycoses [3].
The key factors involved in the pathogenesis of the mycotic
keratitis include adherence, invasiveness, morphogenesis,
and toxigenicity [4]. Fungal lectins are gaining importance
as they are implicated in the process of speciﬁc recognition
between fungal parasites and their host cells, involving
protein-carbohydrate interactions leading to infection [5].
Lectins constitute a heterogeneous group of proteins of
nonimmuneoriginwithnoncatalyticbindingsitescapableof
recognizing and binding reversibly to speciﬁc carbohydrate
moieties [6]. Although several reports are available on
the lectins from higher fungi [7], very few lectins from
animal and plant pathogenic fungi are reported [5, 8–
13]. Further, fungal lectins are drawing greater attention as
many of them exhibit interesting physiological eﬀects such
as lymphomitogenic activity, immunomodulatory eﬀect,
suppression of cell proliferation, and antitumor activity
[14].
The present paper reports the puriﬁcation, characteri-
zation, and mitogenic activity towards human PBMCs of a
lectin from Cephalosporium, a pathogenic fungus, isolated
from the infected eye of a keratitis patient.
2.MaterialsandMethods
2.1. Fungal Culture. The fungus was isolated from the
corneal smears of a female patient aged 48 years with
fungal keratitis. The corneal scrapings were inoculated on
Sabourd’s dextrose agar (SDA) slants and the stock culture
was maintained on SDA slants. Cephalosporium cultures
were grown in 500-ml Erlenmeyer ﬂasks containing 100ml2 Biochemistry Research International
Byrde’s liquid synthetic media (0.696g KH2PO4, 0.149g
KCl, 0.008g ZnSO4·2H2O, 0.2 g MgSO4, 0.2g FeSO4, 0.006g
MnSO4,a n d1gN H 4NO3 per liter of distilled water) with
2% dextrose and incubated at room temperature under
stationary conditions [15]. After 10 days, the mycelial mat
was harvested and washed with distilled water on cheese
cloth. The mycelial mass was subsequently freeze dried and
powdered in a glass mortar, and the ﬁne powder was stored
at −20
◦C and used for the puriﬁcation of lectin.
2.2. Materials. Mucin (porcine stomach, type III), fetuin
(fetal calf serum), PHA-L, Histopaque 1077, and ﬁne
sugars used in hapten inhibition studies were purchased
from Sigma Chemical Co., St. Louis, USA. Sepharose 4B
was obtained from Pharmacia Fine Chemicals, Uppsala,
Sweden. Asialofetuin was prepared as described by Spiro and
Bhoyroo [16]. Asialofetuin-Sepharose 4B, aﬃnity matrix,
was prepared by coupling asialofetuin to cyanogen bromide-
activated Sepharose 4B according to the method of March
[17]. Tritiated thymidine was procured from BRIT (Board of
Radiation and Isotope Technology), India. The tissue culture
ﬂasks and 96 well plates were procured from NUNC (Den-
mark). Human blood samples were obtained from Health
Center, Karnatak University, Dharwad, India, with approval
from Institutional Review Board. All other chemicals used
were of analytical reagent grade.
2.3. Isolation and Puriﬁcation of CSL. Dried Cephalosporium
mycelial powder was homogenized in 50ml (1:50 w/v)
of 50mM sodium phosphate buﬀer, pH 7.2, containing
154mM NaCl (PBS) for 5 minutes and stirred overnight at
4◦C. The extract was centrifuged (9500xg) for 30 minutes
at 4◦C. The resulting supernatant was membrane ﬁltered
(0.45μm) and used for the puriﬁcation of the lectin. The
crude extract was subjected to aﬃnity chromatography
on asialofetuin-Sepharose 4B column (10 × 1.3cm) that
had been equilibrated with PBS and 3ml fractions were
collected at a ﬂow rate of 15ml/hr. The washing of the
column with PBS was continued, until the absorbance of
the eluting fractions reads zero at 280nm (double beam
spectrophotometer, Hitachi 2800). The bound lectin was
eluted with glycine-HCl buﬀer (100mM, pH 2.0) containing
500mM NaCl. Fractions containing lectin activity were
pooled and dialyzed extensively against PBS and stored at
−20
◦C for further studies.
2.4. Hemagglutination Assay and Hapten Inhibition Studies.
Hemagglutination activity of CSL during various stages of
puriﬁcation was determined by the serial twofold dilution
method using trypsinized human erythrocytes in 96 well,
“U” bottom micro titer plates [18]. The highest dilution of
the extract causing visible hemagglutination was regarded
as the titre and the minimum concentration of the protein
was required for agglutination (MCA) as one unit of
hemagglutinating activity. The speciﬁc hemagglutination
a c t i v i t yw a se x p r e s s e da su n i tm g −1 protein. The sugar
speciﬁcity of the puriﬁed lectin was determined by a hapten
inhibition assay. Inhibition assays were carried out by
incubating the lectin sample (with hemagglutinating titre
of 4) with serially diluted sugar/glycoprotein prior to the
addition of erythrocytes in a total volume of 50μl, and
the hemagglutination was visually observed. The minimum
inhibitory concentration of the sugar/glycoprotein was taken
as the inhibitory titre of the hapten.
Protein concentrations were determined routinely by
Lowry’smethod[19]andtotalsugarcontentofthelectinwas
estimated by phenol-sulfuric acid method [20].
2.5. Molecular Mass Estimation. The molecular mass of the
puriﬁed lectin was determined by SDS-PAGE in 15% gel,
accordingtothemethodofLaemmli[21]andbygelﬁltration
chromatography on a superdex G-75 column (1.5 × 80cm,
in PBS) precalibrated with standard proteins of known
molecular weight.
2.6. Binding of CSL to Human PBMCs. Human periph-
eral blood mononuclear cells (PBMCs) were isolated
from the blood of healthy donors by density gradient
using Histopaque-1077 (Sigma) and resuspended in com-
plete medium (RPMI 1640 + 10% FCS). Fluorescein
isothiocyanate-conjugated CSL (FITC-CSL) required for
ﬂow cytometry was prepared using the protocol of Goldman
[22]. The binding of CSL to PBMCs was determined by ﬂow
cytometry. Cells (1 × 105) were incubated with FITC-CSL
(2μg/100μl) for 1 hour on ice and were washed thoroughly
with 50mM PBS and then ﬁxed with 2% freshly prepared
paraformaldehyde. Data were acquired for 10,000 events
using an FACS Vantage (Becton Dickson) equipped with a
488nmargonlaserandanalyzedwithCellquest-prosoftware
fordetermining%positivityandmeanﬂuorescenceintensity
(MFI). Unstained cells that had been processed similarly
were used as negative control.
Receptor-mediated CSL binding to PBMCs was deter-
mined by preincubating FITC-CSL with mucin, fetuin and
asialofetuin (100μg/ml) for 1 hour at room temperature.
This lectin-sugar complex was added to the PBMCs prepa-
r a t i o na n da n a l y z e db yﬂ o wc y t o m e t r y .
2.7. Mitogenic Activity by Tritiated Thymidine Incorporation
Assay. Freshly isolated PBMCs were suspended in RPMI-
1640 containing 10% FCS and 1 × 105 cells/100μl/well were
plated in 96 well tissue culture plate (NUNC, Denmark) and
incubated with CSL concentration ranging from 0.625μg/ml
to 10μg/ml for 72 hours at 37
◦Ci n5 %C O 2. PBMCs
stimulated with PHA-L (0.156μg/ml to 2.5μg/ml, Sigma
Chemicals) were used as positive control. Cells were pulsed
with tritiated thymidine (1μCi /well, BRIT, India) 18 hour
prior to harvesting and incorporation was measured as
counts per minute (CPM).
2.8. Statistical Analysis. Statistical analysis was performed
using student’s t-test and Mann-Whitney rank sum test. A
P-value < .05 was considered to be statistically signiﬁcant.Biochemistry Research International 3

















Original crude extract 41.0 30.053 22.96 1.145 0.087 × 104 2.61 × 104 — 100
Aﬃnity puriﬁed 7.5 0.410 NDb 0.021 4.76 × 104 1.95 × 104 54.71 74.71
a-Minimum concentration of protein required to agglutinate erythrocytes used.
b-Not detected by phenol-sulfuric acid method.
c-Speciﬁc activity: hemagglutinating activity mg−1 protein.










































































Figure 1: Aﬃnity puriﬁcation of Cephalosporium lectin on asialo-
fetuin-Sepharose 4B column. Crude extract was passed through
aﬃnity column, equilibrated in PBS, and the bound lectin was
eluted with elution buﬀer. Fractions of 3.0ml were collected
at a ﬂow rate of 15ml/hr. Absorbance at 280 nm,
Hemagglutinating activity. Inset- SDS-PAGE of aﬃnity puriﬁed
CSL in 15% gel. The puriﬁed lectin (30μg) is indicated in lane 1
andlane2containsstandardmolecularweightmarkers.Thegelwas
stained with Coomassie brilliant blue.
3. Results
3.1. Isolation and Puriﬁcation of the Lectin from the Mycelium
of Cephalosporium. T h el e c t i nw a sp u r i ﬁ e dt oh o m o g e n e i t y
in a single step by aﬃnity chromatography on asialofetuin-
Sepharose 4B column (Figure 1). The fold puriﬁcation
and the total % recovery of the puriﬁed lectin from 1g
of the dry mycelial powder are summarized in Table 1;
the minimum concentration of the protein required for
agglutination (MCA) was found to be 1.145μg for the
crude extract and 0.021μg for the puriﬁed lectin. The
eluted lectin was found to be homogenous as revealed by
single band on SDS-PAGE in 15% gel (Figure 1,I n s e t ) .
Subunit molecular mass of 14kDa was estimated for the
lectin by SDS-PAGE, whereas molecular mass of 57kDa
was estimated by gel ﬁltration chromatography (Figure 2),
suggesting tetrameric nature of the lectin. Puriﬁed CSL
agglutinated the human erythrocytes of all blood groups,
indicating that it has a blood group nonspeciﬁc nature.
Hapten inhibition studies showed that the hemagglutinating
activity of CSL was inhibited by mucin, fetuin, and asialofe-
tuin, with mucin being the most potent inhibitor with


























Figure 2: Calibration curve for the estimation of molecular weight
of CSL by gel ﬁltration chromatography. X-axis represents the
log molecular weight and Y-axis represents K average, marker
proteins; BSA (66kDa), ovalbumin (45kDa), pepsin (34.7kDa),
chymotrypsinogen (25.6kDa) and lysozyme (14.3kDa).
3.2. Binding of CSL to Human PBMCs. To study the inter-
action of CSL with PBMCs, cells were stained with FITC-
CSL and its binding was analysed by ﬂow cytometry. As
depicted in Figure 3(a), 99.62% of the cells were found to be
positive for CSL binding, with mean ﬂuorescence intensity
(MFI) of 411.27, in comparison with control unstained cells
which were set to 1% positivity and the MFI of this 1% cells
was 76.89. The receptor-mediated lectin binding to PBMCs
was conﬁrmed by studying the binding of CSL after pre-
incubationofthelectinwithdiﬀerentcompetingglycoconju-
gates or haptens. Flow cytometry histograms of CSL binding
to PBMCs before and after blocking with mucin, fetuin,
a n da s i a l o f e t u i na r ep r e s e n t e di nF i g u r e s3(a), 3(b), 3(c),
and3(d), respectively. Mucinat100μg/ml concentrationwas
the most eﬀective inhibitor of CSL followed by fetuin and
asialofetuin at 100μg/ml.
3.3. Mitogenic Activity of CSL. Mitogenic eﬀect of CSL
on human PBMCs was determined by tritiated thymi-
dine incorporation assay. CSL stimulated the uptake of
thymidine by human PBMCs in a dose-dependent manner,
with maximum incorporation occurring at 10μg/ml of4 Biochemistry Research International
Table 2: Hapten inhibition studies with puriﬁed CSL.
Glycoprotein Minimum concentration required for inhibition, MIC (μg/50μl)
Mucin (from porcine stomach) 0.785
Fetuin 6.25
Asialofetuin 12.5
∗D-(+)-Galactose, D-(+)-Glucose, D-(+)-Mannose, D-(+)-Arabinose, D-(+)-Fucose, L-(-)-Fucose, β-D(+)-Glucose, 2-Deoxy-D-glucose,
α-L-Rhamnose, 1-Amino-1-deoxy-β-D-glucose, N-Acetyl-D-galactosamine, N-Acetyl-D-glucosamine, N-Acetyl-β-D-mannosamine,
Methyl-α-D-mannopyranoside, Methyl-α-D-galactopyranoside, Methyl-β-D-galactopyranoside, Methyl-β-D-glucopyranoside, 4-
Aminophenyl β-D-galactopyranoside, 4-Aminophenyl β-D-glucopyranoside, N-Acetyl neuraminic acid, β-D-Galactose(1-4) β-D-
glucose (β-Lactulose), β-D-Glucose(1-4)-D-glucose (cellobiose), 6-α-D-Galactopyranosyl-D-glucopyranose (melibiose), and O-α-D-
Galactopyranosyl-(1-6)-α-D-glucopyranosyl-β-D-fructofuranoside (raﬃnose) did not inhibit the lectin activity up to concentrations of












































































Figure 3: Binding of CSL to human PBMCs and inhibition of binding with competing glycoconjugates. PBMCs were stained with FITC-
labeled CSL and subjected to ﬂow cytometric analysis. X-axis, FL1-H on a log scale represents the ﬂuorescence intensity of cells stained
with FITC labeled CSL. Y-axis represents cell number. (a) The histoplot shows proﬁles of the unstained cells (UNS) and cells stained with
















Figure 4: Mitogenic activity of CSL. PBMCs were isolated from
bloodofhealthydonorsandexposedtoserialconcentrationsofCSL
(0.625–10μg/ml) and PHA-L (0.16–2.5μg/ml) for 72 hours and
proliferation was measured by tritiated thymidine incorporation
assay as counts per minute (CPM). The data are presented as mean
± SE of four independent experiments done in triplicates.
the diﬀerent doses tested (0.625–10μg/ml), whereas PHA-
L, a positive control exhibited maximum proliferation at
1.25μg/ml (Figure 4).
4. Discussion
In the present study, the lectin from human pathogenic fun-
gus Cephalosporium isolated from mycotic keratitis patient
was puriﬁed to homogeneity in a single step by aﬃnity
chromatography on asialo fetuin-Sepharose 4B. CSL, a
tetramer, without blood group speciﬁcity, has complex sugar
speciﬁcity and mitogenic activity on human PBMCs. In
the past decade, sizeable numbers of fungal lectins are
reported and majority of them are from higher fungi, mostly
from fruiting bodies of mushrooms [7, 23]. However, very
few lectins are known from the mycelia forming lower
fungi, particularly the pathogenic fungi, although fungal
lectins are implicated in host parasite interactions [5].
There is a growing realization that the fungal lectins like
bacterial lectins also play an important role in adhesion
and infection process. Several hyaline ﬁlamentous fungi are
considered as opportunistic human pathogens [3]. Most of
these pathogens express surface factors, lectins that mediate
binding to extra cellular matrix glycoproteins of host cells.
Such a binding would facilitate the fungal adherence and
can induce immunomodulatory eﬀect on the host cells. In
this regard, the CSL exerts mitogenic activity on human
PBMCs. So far, very few lectins from human pathogenic
fungi are reported including Candida albicans, Candida
glabrata, Histoplasma capsulatum, Aspergillus fumigatus,a n d
Trycophyton rubrum [5, 10, 24, 25]. The lectin from C.
albicans which recognizes Fucα1-2Galβ, occurring on all
blood group substances of ABO types, is implicated in the
adherence to human buccal epithelial cells [9]. A 32kDa
lectin puriﬁed from A. fumigatus, with sialic acid speciﬁcity
is suggested to play an important role in the attachment of
conidiatoextracellularmatrixcomponentsofhostcells[10].
A. fumigatus is a known opportunistic pathogen responsible
for variety of ophthalmic infections such as dacryocystitis,
scleritis and endophthalmitis [3]. An extracellular agglutinin
from Trycophyton rubrum, a well-known dermatophyte, has
speciﬁcitytowardssialooligosaccharidesisimplicatedforthe
adhesion to host cells [25].
There is no direct evidence available conﬁrming the role
of lectins from these pathogens in mediating host parasite
interactions and also in their immunomodulatory eﬀects on
the host cells. On the contrary, several lectins from higher
fungi are known to exert interesting immunomodulatory
eﬀects. Lectins from V. volvacea and Boletus satanas Lenz
exhibitmitogeniceﬀectsonhumanPBMCs[26,27],whereas
Agrocybe cylindracea and Schizophyllum commune exerts
mitogenic eﬀect on mouse splenocytes [28, 29]. Some
of the mitogenic lectins like those from V. volvacea, F.
velutipes, and Ganoderma lucidum were shown to exhibit
immunomodulatory eﬀects [30–32], and such mitogenic
lectins have potential applications as important diagnostic
and experimental tool to study the various aspects of cell
growth and diﬀerentiation. The receptor mediated binding
of CSL to human PBMCs was clearly demonstrated, as it
can be eﬀectively blocked by competing glycoconjugates
such as mucin, fetuin and asialofetuin. These results sub-
stantiate our observations by hapten inhibition studies that
CSL has preferential aﬃnity towards mucin compared to
fetuin or asialofetuin. The mitogenic potential of CSL was
demonstrated by the observed dose-dependent increase in
proliferation of PBMCs.
In summary, the lectin with complex sugar speciﬁcity
puriﬁed from the pathogenic fungus Cephalosporium, which
is responsible for ophthalmic mycoses, exhibits mitogenic
and hemagglutinating activity. It is one of the few lectins
characterized from pathogenic fungi reported and the infor-
mation provides valuable account for understanding the
lectin mediated host-parasite interaction in fungal infec-
tions.
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